These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Usefulness of echocardiography in the identification of an excessive increase in pulmonary arterial pressure in patients with systemic sclerosis. Ciurzyński M; Bienias P; Irzyk K; Rymarczyk Z; Kostrubiec M; Szewczyk A; Glińska-Wielochowska M; Zyłkowska J; Kurzyna M; Pruszczyk P Kardiol Pol; 2011; 69(1):9-15. PubMed ID: 21267956 [TBL] [Abstract][Full Text] [Related]
7. Clinical and laboratory features of scleroderma patients with pulmonary hypertension. Yamane K; Ihn H; Asano Y; Yazawa N; Kubo M; Kikuchi K; Soma Y; Tamaki K Rheumatology (Oxford); 2000 Nov; 39(11):1269-71. PubMed ID: 11085808 [TBL] [Abstract][Full Text] [Related]
10. Lung Density and Pulmonary Artery Diameter are Predictors of Pulmonary Hypertension in Systemic Sclerosis. Bakker ME; Ninaber MK; Stolk J; Kroft LJM; Schouffoer AA; de Vries Bouwstra JK; van Wijngaarden SE; Stoel BC J Thorac Imaging; 2017 Nov; 32(6):391-397. PubMed ID: 28549020 [TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of pulmonary hypertension in systemic sclerosis and related disorders. A Doppler echocardiographic study of 135 Japanese patients. Murata I; Takenaka K; Yoshinoya S; Kikuchi K; Kiuchi T; Tanigawa T; Ito K Chest; 1997 Jan; 111(1):36-43. PubMed ID: 8995990 [TBL] [Abstract][Full Text] [Related]
12. Pulmonary Arterial Hemodynamic Assessment by a Novel Index in Systemic Sclerosis Patients: Pulmonary Pulse Transit Time. Dogan M; Efe TH; Cimen T; Ozisler C; Felekoglu MA; Ertem AG; Erat M; Yiginer O; Tulmac M Lung; 2018 Apr; 196(2):173-178. PubMed ID: 29445936 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of exercise pulmonary arterial hypertension in scleroderma. Callejas-Rubio JL; Moreno-Escobar E; de la Fuente PM; Pérez LL; Fernández RR; Sánchez-Cano D; Mora JP; Ortego-Centeno N J Rheumatol; 2008 Sep; 35(9):1812-6. PubMed ID: 18634147 [TBL] [Abstract][Full Text] [Related]
14. Pericardial abnormalities predict the presence of echocardiographically defined pulmonary arterial hypertension in systemic sclerosis-related interstitial lung disease. Fischer A; Misumi S; Curran-Everett D; Meehan RT; Ulrich SK; Swigris JJ; Frankel SK; Cosgrove GP; Lynch DA; Brown KK Chest; 2007 Apr; 131(4):988-92. PubMed ID: 17426200 [TBL] [Abstract][Full Text] [Related]
15. Serum levels of interleukin-18-binding protein isoform a: Clinical association with inflammation and pulmonary hypertension in systemic sclerosis. Nakamura K; Asano Y; Taniguchi T; Minatsuki S; Inaba T; Maki H; Hatano M; Yamashita T; Saigusa R; Ichimura Y; Takahashi T; Toyama T; Yoshizaki A; Miyagaki T; Sugaya M; Sato S J Dermatol; 2016 Aug; 43(8):912-8. PubMed ID: 26777734 [TBL] [Abstract][Full Text] [Related]
16. Plasma plasmin-alpha2-plasmin inhibitor complex levels are increased in systemic sclerosis patients with pulmonary hypertension. Jinnin M; Ihn H; Yamane K; Asano Y; Yazawa N; Tamaki K Rheumatology (Oxford); 2003 Feb; 42(2):240-3. PubMed ID: 12595617 [TBL] [Abstract][Full Text] [Related]
17. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease. Benyamine A; Heim X; Resseguier N; Bertin D; Gomez C; Ebbo M; Harlé JR; Kaplanski G; Rossi P; Bardin N; Granel B Rheumatol Int; 2018 May; 38(5):813-819. PubMed ID: 29455320 [TBL] [Abstract][Full Text] [Related]
18. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma. Garin MC; Highland KB; Silver RM; Strange C J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563 [TBL] [Abstract][Full Text] [Related]
19. Significance of serum uric acid in pulmonary hypertension due to systemic sclerosis: a pilot study. Dimitroulas T; Giannakoulas G; Dimitroula H; Sfetsios T; Parcharidou D; Karvounis H; Settas L Rheumatol Int; 2011 Feb; 31(2):263-7. PubMed ID: 20658290 [TBL] [Abstract][Full Text] [Related]
20. High arterial compliance in cirrhosis is related to low adrenaline and elevated circulating calcitonin gene related peptide but not to activated vasoconstrictor systems. Henriksen JH; Møller S; Schifter S; Abrahamsen J; Becker U Gut; 2001 Jul; 49(1):112-8. PubMed ID: 11413119 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]